180 results
Page 2 of 9
8-K
EX-99.1
7if4a717wb67idrj7m3p
17 Feb 22
Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
7:49am
424B7
v1eusziqq5
5 Nov 21
Prospectus with selling stockholder info
4:16pm
8-K
EX-99.1
sq02lis9n997
28 Oct 21
Repligen Reports Third Quarter 2021 Financial Results
7:55am
8-K
EX-99.1
4b41hr9i
16 Sep 21
Proposed acquisition strengthens Repligen’s Proteins business
7:53am
8-K
EX-99.1
ltyib
27 Jul 21
Repligen Reports Second Quarter 2021 Financial Results
7:42am
DEFR14A
u8rdgy29fsmzu1mww3y3
5 May 21
Revised proxy
4:16pm
8-K
EX-99.1
vis0 2xfynwcw
4 May 21
Repligen Reports First Quarter 2021 Financial Results
7:54am
8-K
EX-99.1
4z87sr
24 Feb 21
Repligen Reports Fourth Quarter and Full Year 2020 Financial Results
7:54am
8-K
EX-3.1
k3c qriaso9tt
28 Jan 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
9jdxaac 4v
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.2
ap5my5vb8 besogj
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
424B5
vqi53hd
8 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
v1r ugzqn
7 Dec 20
Prospectus supplement for primary offering
7:24am